Inventor

HOFMANN MARCO

DE11 patents

⚠️ This page may combine multiple inventors who share the name “HOFMANN MARCO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFMANN MARCO

3 patents

US8124711B2Feb 28, 2012

Ru complexes, production and use thereof

HOFMANN MARCO5 citations58

US8207241B2Jun 26, 2012

Platinum catalysts supported on nanosize titanium dioxide, their use in hydrosilylation and compositions comprising such catalysts

HOFMANN MARCO0 citations38

US9778642B2Oct 3, 2017

Protection unit for a programmable data-processing system

HOFMANN MARCO0 citations30

WACKER CHEMIE AG

2 patents

US7803893B2Sep 28, 2010

Hydrosilylation process in the presence of ruthenium catalyzers

WACKER CHEMIE AG7 citations72

US8013095B2Sep 6, 2011

Ru sulfoxide complexes, their preparation and use

WACKER CHEMIE AG0 citations29

GRAMMER AG

1 patent

US7575206B2Aug 18, 2009

Vehicle seat with automatic height adjustment and method therefore

GRAMMER AG24 citations91

BAYERISCHE MOTOREN WERKE AG

1 patent

US7748043B2Jun 29, 2010

Method for authenticating, in particular, software components that can be loaded into a control unit of a motor vehicle

BAYERISCHE MOTOREN WERKE AG3 citations59

CSL Behring Lengnau AG

1 patent

US11141466B2Oct 12, 2021

Modulation of FVIII immunogenicity by truncated VWF

CSL Behring Lengnau AG0 citations57

ROSCHER ANJA

1 patent

US8697818B2Apr 15, 2014

Alkoxy-crosslinking rubber mixtures comprising niobium or tantalum condensation catalysts

ROSCHER ANJA2 citations57

CSL Innovation Pty Ltd

1 patent

US12577552B2Mar 17, 2026

Factor IX variants and uses thereof in therapy

CSL Innovation Pty Ltd0 citations49

BOEHRINGER INGELHEIM INT

1 patent

US11261184B2Mar 1, 2022

[1,6]naphthyridine compounds and derivatives as CDK8/CDK19 inhibitors

BOEHRINGER INGELHEIM INT0 citations44